The pharmaceutical industry's approach to neurodegenerative diseases has undergone significant transformation, with Alzheimer's disease research representing one of the most intensive areas of drug development activity. Understanding pipeline dynamics and market forces provides essential insights for stakeholders navigating this complex therapeutic landscape. Pipeline Innovation...